Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: The Whitehall II cohort study

European Heart Journal

Volumn 36, Issue 9, 2015, Pages 551-559

  Hinnouho, Guy Marino ^a,b   Czernichow, Sebastien ^a,b,c   Dugravot, Aline ^a,b   Nabi, Hermann ^a,b   Brunner, Eric J ^d   Kivimaki, Mika ^d   Singh Manoux, Archana ^a,b,d,e  

^a HÔPITAL PAUL BROUSSE   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^c HÔPITAL AMBROISE PARÉ   (France)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e Versailles Saint Quentin en Yvelines University   (France)

Author keywords

Cardiovascular diseases; Metabolically healthy obesity; Type 2 diabetes

Indexed keywords

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; FEMALE; FOLLOW UP; HEALTH STATUS; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLICALLY HEALTHY OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHENOTYPE; PRIORITY JOURNAL; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; ENGLAND; EPIDEMIOLOGY; METABOLICALLY BENIGN OBESITY; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; LONDON; MALE; MIDDLE AGED; OBESITY, METABOLICALLY BENIGN; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84924345873     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu123     Document Type: Article

References (17)

1. Song Y, Manson JE, Meigs JB, Ridker PM, Buring JE, Liu S. Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women. Am J Cardiol 2007;100:1654-1658.
2. Thomsen M, Nordestgaard BG. Myocardial infarction and ischemic heart disease in overweight and obesity with and without metabolic syndrome. JAMA Intern Med 2014;174:15-22.
3. Abdullah A, Wolfe R, Stoelwinder JU, de Court M, Stevenson C, Walls HL, Peeters A. The number of years lived with obesity and the risk of all-cause and cause-specific mortality. Int J Epidemiol 2011;40:985-996.
4. Marmot M, Brunner E. Cohort profile: the Whitehall II study. Int J Epidemiol 2005;34: 251-256.
5. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894:i-xii:1-253.
6. Cooper GR. Methods for determining the amount of glucose in blood. CRC Crit Rev Clin Lab Sci 1973;4:101-145.
7. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994;90:583-612.
8. Rose G, Hamilton PS, Keen H, Reid DD, McCartney P, Jarrett RJ. Myocardial ischaemia, risk factors and death from coronary heart-disease. Lancet 1977;1:105-109.
9. Tabak AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimaki M, Witte DR. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 2009;373:2215-2221.
10. Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM, DAgostino RB. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006;91:2906-2912.
11. Appleton SL, Seaborn CJ, Visvanathan R, Hill CL, Gill TK, Taylor AW, Adams RJ. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care 2013;36:2388-2394.
12. Sundstrom J, Riserus U, Byberg L, Zethelius B, Lithell H, Lind L. Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. BMJ 2006;332:878-882.
13. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparisonwith the euglycemic insulin clamp. Diabetes Care1999;22: 1462-1470.
14. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, Sowers MR. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008;168:1617-1624.
15. Wildman RP. Healthy obesity. Curr Opin Clin Nutr Metab Care 2009;12:438-443.
16. Janssen I, Katzmarzyk PT, Ross R. Duration of overweight and metabolic health risk in American men and women. Ann Epidemiol 2004;14:585-591.
17. Aguilar-Salinas CA, Garcia EG, Robles L, Riano D, Ruiz-Gomez DG, Garcia-Ulloa AC, Melgarejo MA, Zamora M, Guillen-Pineda LE, Mehta R, Canizales-Quinteros S, Tusie Luna MT, Gomez-Perez FJ. High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J Clin Endocrinol Metab 2008;93:4075-4079.